Literature DB >> 22635233

Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome.

A Banzato1, R Frasson, L Acquasaliente, E Bison, A Bracco, G Denas, S Cuffaro, A Hoxha, A Ruffatti, S Iliceto, V De Filippis, V Pengo.   

Abstract

Beta2-glycoprotein I (β(2)GPI), a relevant antigen in Antiphospholipid Syndrome (APS), binds anionic macromolecules including heparin (Hep). A possible formation of ternary complexes between β(2)GPI, antibodies and Hep in APS is thus possible. The aim of this study was to evaluate Hep-β(2)GPI interaction in patients with APS. The affinity of Heps of different length, including unfractionated Hep (UFH), low-molecular weight Hep (enoxaparin) and pentasaccharide (fondaparinux), to human β(2)GPI was estimated by fluorescence spectroscopy, yielding dissociation constant (K(d)) values of 1.1, 24.0 and 89.4 µM, demonstrating that the longer UFH binds to β(2)GPI far more tightly than the shorter ones. Plasma and protein G-purified IgGs from eight patients with APS (i.e. five with thromboembolic disease and three with catastrophic APS), were fractionated by affinity chromatography using a Hep (UFH)-bound column, eluted with a linear NaCl gradient. For each chromatographic analysis, fractions were collected in the whole NaCl gradient and tested by ELISA for the presence of β(2)GPI and anti-β(2)GPI IgG. The results of Hep-affinity chromatography and ELISAs concurrently indicate that either β(2)GPI and anti-β(2)GPI IgG elute from the Hep column in the same chromatographic peak, at a retention time identical to that of the purified, isolated β(2)GPI, thus suggesting that circulating immunocomplexes containing β(2)GPI are present in patients with APS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22635233     DOI: 10.1177/0961203312440347

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Catastrophic antiphospholipid syndrome presented with sudden renal failure and history of long-lasting psychosis and hypertension in a 42 years old women.

Authors:  Saeed Mardani; Hamid Nasri
Journal:  J Nephropathol       Date:  2013-04-01

Review 2.  Clinical relevance of β₂-glycoprotein-I plasma levels in antiphospholipid syndrome (APS).

Authors:  Alessandra Banzato; Vittorio Pengo
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

3.  The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome.

Authors:  Eliza Ruben; William Planer; Mathivanan Chinnaraj; Zhiwei Chen; Xiaobing Zuo; Vittorio Pengo; Vincenzo De Filippis; Ravi K Alluri; Keith R McCrae; Paolo Macor; Francesco Tedesco; Nicola Pozzi
Journal:  J Biol Chem       Date:  2020-06-09       Impact factor: 5.157

4.  Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

Authors:  Francesco Tedesco; Maria Orietta Borghi; Maria Gerosa; Cecilia Beatrice Chighizola; Paolo Macor; Paola Adele Lonati; Alessandro Gulino; Beatrice Belmonte; Pier Luigi Meroni
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

5.  Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.

Authors:  Dolores Pérez; Ljudmila Stojanovich; Laura Naranjo; Natasa Stanisavljevic; Gordana Bogdanovic; Manuel Serrano; Antonio Serrano
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

6.  Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.

Authors:  Paola Adele Lonati; Mariangela Scavone; Maria Gerosa; Maria Orietta Borghi; Francesca Pregnolato; Daniele Curreli; Gianmarco Podda; Eti Alessandra Femia; Wilma Barcellini; Marco Cattaneo; Francesco Tedesco; Pier Luigi Meroni
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

7.  Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.

Authors:  Laura Naranjo; Ljudmila Stojanovich; Aleksandra Djokovic; Laura Andreoli; Angela Tincani; Maria Maślińska; Savino Sciascia; Maria Infantino; Sara Garcinuño; Kinga Kostyra-Grabczak; Mariangela Manfredi; Francesca Regola; Natasa Stanisavljevic; Milomir Milanovic; Jovica Saponjski; Dario Roccatello; Irene Cecchi; Massimo Radin; Maurizio Benucci; Daniel Pleguezuelo; Manuel Serrano; Yehuda Shoenfeld; Antonio Serrano
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

8.  Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events.

Authors:  José A Martínez-Flores; Manuel Serrano; Dolores Pérez; Gómez de la Cámara A; David Lora; Luis Morillas; Rosa Ayala; Estela Paz-Artal; José M Morales; Antonio Serrano
Journal:  J Atheroscler Thromb       Date:  2016-04-11       Impact factor: 4.928

Review 9.  Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Cristina Belizna; Albert Selva-O'Callaghan; Josep Pardos-Gea; Angela Quintana; Arsene Mekinian; Ariadna Anunciacion-Llunell; Francesc Miró-Mur
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.